Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Kura Oncology (KURA) EBT Margin (2024 - 2025)

Kura Oncology (KURA) has disclosed EBT Margin for 2 consecutive years, with 466.82% as the latest value for Q4 2025.

  • Quarterly EBT Margin fell 473456.0% to 466.82% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 412.51% through Dec 2025, down 1103419.0% year-over-year, with the annual reading at 412.51% for FY2025, 9336.0% down from the prior year.
  • EBT Margin for Q4 2025 was 466.82% at Kura Oncology, down from 357.19% in the prior quarter.
  • The five-year high for EBT Margin was 13204.85% in Q3 2024, with the low at 466.82% in Q4 2025.